BioNTech SE: BioNTech Strengthens Manufacturing Capabilities

Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugsThe new plasmid manufacturing facility aims to increase BioNTech's autonomy and flexibility in manufacturing

Related Keywords

Germany , United States , United Kingdom , Spain , Belgium , Federal Republic Of Germany , German , Sylke Maas , Biontech Marburg , Olaf Scholz , Schwierige Zeiten , Ugur Sahin , Fosun Pharma , Exchange Commission , Pfizer , Genentech , Company Fixvac , Roche Group , Chancellor Olaf Scholz , Chief Executive Officer , Chief Medical , Federal Republic , New Technologies , Private Securities Litigation Reform Act , Quarterly Report , Biontech , Trengthens , Manufacturing , Capabilities , First , House , Plasmid , Facility ,